title: Spondyloarthropathy: interleukin 23 and disease modification.
authors.affiliation: Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK. Electronic address: jonsherlock1-bd@yahoo.co.uk.
authors.forename: Jonathan P
authors.initials: JP
authors.lastname: Sherlock
authors.affiliation: Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
authors.forename: Peter C
authors.initials: PC
authors.lastname: Taylor
authors.affiliation: Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK.
authors.forename: Christopher D
authors.initials: CD
authors.lastname: Buckley
authors.affiliation: Merck Research Laboratories, Palo Alto, CA, USA.
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Cua
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D006801:Humans; D053759:Interleukin-23 / Q000627:therapeutic use*; D025242:Spondylarthropathies / Q000188:drug therapy*
chemical_list: D018501:Antirheumatic Agents; D053759:Interleukin-23